{"data":[{"id":"eaaad966-0669-485a-a8c0-5d59d4df4025","company_name":"ステラ設備工業株式会社","company_name_en":null,"corporate_number":"2120001233551","authority":"大阪府","authorities":["大阪府"],"authority_count":1,"action_types":["許可取消"],"regional_record_count":1,"source_document_count":1,"law_name":"建設業法","action_type":"許可取消","action_date":"2023-11-27","announcement_date":"2026-04-25","violation_summary":"当該建設業者は、建設業法第７条第１号及び建設業法施行規則第７条第１号の規定に基づく経営業務の管理責任者並びに同法第７条第２号に規定する営業所の専任技術者が、令和３年12月13日に当該建設業者の取締役を解任され、令和５年７月には他の建設業者の常勤の役員となるなど、当該建設業者の常勤の役員として職務に従事しておらず、また、当該建設業者の営業所に常勤して専ら職務に従事しておらず、同条第１号及び第２号に掲げる許可の基準を満たさなくなった。","violation_summary_en":"The Osaka Prefectural Government revoked the construction business license of Stella Setsubi Kogyo Co., Ltd. on November 27, 2023, due to the company's management personnel not fulfilling licensing requirements after being dismissed from their roles and not engaging in duties at the company's office.","penalty_amount":null,"is_verified":true,"record_verified":true,"entity_match":{"status":"confirmed","confidence":100,"method":"source_corporate_number_nta_current_name","notes":"国税庁法人番号データとの独立照合で対象法人を確認しました（source_corporate_number_nta_current_name）。"},"human_review_status":"machine_reviewed","source_url":"https://www.mlit.go.jp/nega-inf/cgi-bin/search.cgi?jigyoubunya=kensetugyousya&EID=search&no=1052","url":"https://regbase.jp/enforcement/kensetsu-gyoho-suterashe-bei-gong-ye-20231127"},{"id":"f606316e-1b5c-45ce-93f7-00ad4acb65d3","company_name":"株式会社ＴＥＲＡ　ｃｏｒｐｏｒａｔｉｏｎ","company_name_en":null,"corporate_number":null,"authority":"東京都","authorities":["東京都"],"authority_count":1,"action_types":["指示"],"regional_record_count":1,"source_document_count":1,"law_name":"宅地建物取引業法","action_type":"指示","action_date":"2023-07-20","announcement_date":"2026-04-25","violation_summary":"令和４年７月に、借主から建物賃貸借契約の申込みを受けた際に、\n①本物件の概要情報の調査を怠り、本物件の正しい築年月を確認することなく、実際の築年月よりも新しい築年月を表示して、著しく事実に相違する又は実際のものより著しく優良であり、若しくは有利であると人を誤認させる広告を行った。\n②本件契約の成立前に、借主から依頼を受けた媒介関係から借主の認容のないまま離脱したにもかかわらず、契約成立時に仲介手数料に充当する名目で、契約の申込みを受けた際に借主から預かった金員について、借主と連絡をとるなどして返還すべきところ、返還に向けた適切な措置を怠り、被処分者の事務所において当該金員を約５か月間にわたり漫然と保管し続け、取引の公正を害する業務を行った。","violation_summary_en":"In July 2022, the company was instructed by Tokyo Metropolitan Government for violations related to real estate advertising and handling of client funds, including misrepresenting property details and improper retention of client deposits for about five months.","penalty_amount":null,"is_verified":true,"record_verified":true,"entity_match":{"status":"unresolved","confidence":92,"method":"nta_strict_name_municipality_supported","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"needs_review","source_url":"https://www.mlit.go.jp/nega-inf/cgi-bin/search.cgi?jigyoubunya=takuti&EID=search&no=88","url":"https://regbase.jp/enforcement/takken-gyoho-teracorporation-20230720"},{"id":"6ea44d3d-d610-49eb-9ff5-14e4683e498e","company_name":"ステラファーマ株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["先駆け審査指定制度対象品目の募集"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"先駆け審査指定制度対象品目の募集","action_date":"2017-10-05","announcement_date":"2026-04-27","violation_summary":"厚生労働省は、革新的医薬品・医療機器・再生医療等製品を日本で早期に実用化することを目的として、その開発を促進するために、平成27年４月１日に「先駆け審査指定制度」を創設しました。","violation_summary_en":"The Ministry of Health, Labour and Welfare established the 'Designated Fast-Track Review System' on April 1, 2015, to promote the development of innovative pharmaceuticals, medical devices, regenerative medicine products, etc., with the aim of accelerating their practical application in Japan.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000179802.html","url":"https://regbase.jp/enforcement/yakkiho-suterahuama-20171005"},{"id":"c363acd7-9d04-4456-856d-8c1e422bfba0","company_name":"アステラス製薬株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["先駆け審査指定制度対象品目の募集"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"先駆け審査指定制度対象品目の募集","action_date":"2017-10-05","announcement_date":"2026-04-27","violation_summary":"厚生労働省は、革新的医薬品・医療機器・再生医療等製品を日本で早期に実用化することを目的として、その開発を促進するために、平成27年４月１日に「先駆け審査指定制度」を創設しました。","violation_summary_en":"The Ministry of Health, Labour and Welfare established the 'Designated Priority Review System' on April 1, 2015, to promote the development of innovative pharmaceuticals, medical devices, regenerative medicine products, etc., with the aim of facilitating their early practical use in Japan.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000179802.html","url":"https://regbase.jp/enforcement/yakkiho-asuterasuzhi-yao-20171005"},{"id":"7892b838-0169-4d77-ba30-0e2208aafd56","company_name":"ステラファーマ株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["先駆け審査指定制度対象品目の募集"],"regional_record_count":1,"source_document_count":1,"law_name":"薬事法","action_type":"先駆け審査指定制度対象品目の募集","action_date":"2017-10-05","announcement_date":"2026-04-03","violation_summary":"SPM-011 ※再発悪性神経膠腫・切除不能な局所再発頭頸部癌並びに局所進行頭頸部癌（非扁平上皮癌）","violation_summary_en":"SPM-011 Recurrent malignant glioma, inoperable local recurrence of head and neck cancer, and locally advanced head and neck cancer (non-squamous cell carcinoma)","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000179802.html","url":"https://regbase.jp/enforcement/other-suterahuama-20171005"},{"id":"e66a4671-243f-47a9-ab17-ed50b3e9e46e","company_name":"アステラス製薬株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["先駆け審査指定制度対象品目の募集"],"regional_record_count":1,"source_document_count":1,"law_name":"薬事法","action_type":"先駆け審査指定制度対象品目の募集","action_date":"2017-10-05","announcement_date":"2026-04-03","violation_summary":"ASP2215 初回再発または治療抵抗性のFLT3遺伝子変異陽性急性骨髄性白血病","violation_summary_en":"ASP2215 for initial relapse or treatment-resistant FLT3 gene mutation-positive acute myeloid leukemia","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000179802.html","url":"https://regbase.jp/enforcement/other-asuterasuzhi-yao-20171005"},{"id":"21dd1ca0-6613-40c1-bf69-7b8178ff0af5","company_name":"ステラファーマ株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["行政指導"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"行政指導","action_date":"2017-04-21","announcement_date":"2026-04-27","violation_summary":"「先駆け審査指定制度」の対象品目として指定された医薬品の名称、予定される効能または効果、申請者の氏名または名称を記載。","violation_summary_en":"Listed the names of pharmaceuticals designated as target items under the Priority Review Designation System, along with their intended effects or efficacy and the applicant's name or organization.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000162665.html","url":"https://regbase.jp/enforcement/yakkiho-suterahuama-20170421"},{"id":"3b347441-2449-44f7-81bf-46f05cef151b","company_name":"ステラファーマ株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["指定"],"regional_record_count":1,"source_document_count":1,"law_name":"医薬品医療機器等法","action_type":"指定","action_date":"2017-02-28","announcement_date":"2026-05-09","violation_summary":"ホウ素中性子捕捉療法（BNCT）に用いる中性子線照射装置。","violation_summary_en":"Stella Pharma Co., Ltd. was designated by the Ministry of Health, Labour and Welfare on February 28, 2017, for using a neutron beam irradiation device intended for Boron Neutron Capture Therapy (BNCT).","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000153128.html","url":"https://regbase.jp/enforcement/other-suterahuama-20170228"},{"id":"abfff2b1-c28d-4def-ae2d-4e3ab4fecd4f","company_name":"ステラファーマ株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["指定"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"指定","action_date":"2017-02-28","announcement_date":"2026-05-02","violation_summary":"ホウ素中性子捕捉療法（BNCT）に用いる中性子線を照射するための装置である。","violation_summary_en":"Stella Pharma Co., Ltd. was designated by the Ministry of Health, Labour and Welfare on February 28, 2017, under the Pharmaceutical and Medical Device Act for an apparatus used to irradiate neutron beams for Boron Neutron Capture Therapy (BNCT).","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000153128.html","url":"https://regbase.jp/enforcement/yakkiho-suterahuama-20170228"},{"id":"5418ead6-3deb-46ef-af00-5e2334e4c2ab","company_name":"アステラス製薬株式会社","company_name_en":null,"corporate_number":null,"authority":"厚生労働省","authorities":["厚生労働省"],"authority_count":1,"action_types":["行政指導"],"regional_record_count":1,"source_document_count":1,"law_name":"薬機法","action_type":"行政指導","action_date":"2015-10-27","announcement_date":"2026-04-10","violation_summary":"厚生労働省は、今年８月に指定申請があった50品目の医薬品について評価を行い、本日付けで以下の６品目を「先駆け審査指定制度」の対象品目として初めて指定しました。","violation_summary_en":"The Ministry of Health, Labour and Welfare evaluated 50 pharmaceutical products for which designation applications were submitted in August this year, and today designated six of these products as subject to the 'Pioneering Review Designation System' for the first time.","penalty_amount":null,"is_verified":false,"record_verified":false,"entity_match":{"status":"unresolved","confidence":85,"method":"nta_strict_name_nationally_unique","notes":"A current-policy Corporate Number match to a verified company profile is not available."},"human_review_status":"unreviewed","source_url":"https://www.mhlw.go.jp/stf/houdou/0000102009.html","url":"https://regbase.jp/enforcement/yakkiho-asuterasuzhi-yao-20151027"}],"meta":{"query":"株式会社ＴＥＲＡ　ｃｏｒｐｏｒａｔｉｏｎ","corporate_number":null,"law":null,"authority":null,"action_type":null,"count":10,"api_docs":"https://regbase.jp/api-docs","openapi_schema":"https://regbase.jp/api/openapi.json","llms":"https://regbase.jp/llms.txt","usage_note":"Use RegBase for targeted public-source screening of Japanese companies and enforcement records. Absence of returned records is not a clearance, legal opinion, sanctions result, or credit decision.","rate_limit":{"limit":10,"window_seconds":60,"remaining":7,"reset_at":"2026-08-04T18:35:35.910Z"},"daily_rate_limit":{"limit":300,"window_seconds":86400,"remaining":62,"reset_at":"2026-08-05T18:34:35.910Z"}}}